The quest for novel therapeutics is an ongoing endeavor, heavily reliant on the availability of sophisticated chemical building blocks. Among these, heterocyclic compounds like 7-Bromo-2,4-dichloroquinazoline (CAS: 959237-68-4) stand out for their versatility and utility in synthesizing complex pharmaceutical molecules. As a dedicated manufacturer and supplier, NINGBO INNO PHARMCHEM CO.,LTD. recognizes the critical role this intermediate plays in driving pharmaceutical innovation and offers it to researchers worldwide.

7-Bromo-2,4-dichloroquinazoline, with its molecular formula C8H3BrCl2N2 and a molecular weight of 277.93, is a cornerstone in the development of new drugs. Its structure features a quinazoline core substituted with bromine and two chlorine atoms, providing multiple reactive sites for chemists to exploit. This makes it an exceptionally adaptable intermediate for creating diverse chemical libraries. Typically appearing as a beige or yellow powder, its guaranteed purity of 98% minimum ensures that synthetic pathways are robust and reliable, a non-negotiable aspect in pharmaceutical development.

The primary application of 7-Bromo-2,4-dichloroquinazoline lies in its role as a key intermediate in the synthesis of Active Pharmaceutical Ingredients (APIs). The quinazoline scaffold is prevalent in many approved drugs, particularly those used in oncology, cardiovascular treatments, and as kinase inhibitors. By incorporating this brominated and chlorinated quinazoline derivative into their synthetic routes, researchers can efficiently construct molecules with desired biological activities. The availability of this compound from reputable manufacturers in China provides a cost-effective avenue for drug discovery programs aiming to explore novel therapeutic agents.

Beyond API synthesis, 7-Bromo-2,4-dichloroquinazoline finds application in broader organic synthesis research. Its functional groups allow for various coupling reactions, nucleophilic substitutions, and other transformations, enabling the creation of novel heterocyclic systems with potential applications in material science, agrochemicals, and beyond. For scientists looking to purchase this versatile compound, partnering with a supplier that emphasizes consistent quality and technical support is paramount. This ensures that the building block meets the stringent requirements of research and development projects, from initial screening to preclinical studies.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying high-quality 7-Bromo-2,4-dichloroquinazoline to the global research community. We understand that reliable access to such critical intermediates is fundamental to accelerating the pace of drug discovery. We encourage researchers and procurement specialists to reach out for inquiries regarding purchase, pricing, and bulk order requirements. Our goal is to be your trusted partner in advancing scientific breakthroughs through high-quality chemical solutions.